Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M551Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M9.4EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)17.5Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book6.110-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.3PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M4,846,503ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BBH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Honig, BarryDirector 2016-07-08Buy20,000$0.3136603.23view
Nadeau, SteveSenior Officer 2016-07-08Buy4,500$1.249075.81view
haukedal, peter lawrence10% Security Holder 2016-07-08Buy41,000$0.07162442.86view
haukedal, peter lawrence10% Security Holder 2016-07-08Buy9,000$0.07162442.86view
Roodenburg, Anthony RalphDirector, Senior Officer 2016-07-08Buy100,000$0.1575753.33view
Churcher, Dale LeeworthySenior Officer 2016-07-08Sell39,377$6.551637.1view
Sanderson, Robert KeithDirector 2016-07-08Buy15,000$0.04284350view
International Finance Corporat10% Security Holder 2016-07-08Sell1,000,000$0.05227460view
Meade, Harlan DonnleyDirector, Senior Officer 2016-07-08Buy1,500$0.1671012.5view
Meade, Harlan DonnleyDirector, Senior Officer 2016-07-08Buy4,000$0.1863111.11view

Quarterly/Annual Reports about BBH:

    News about BBH:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Why Did Alnylam Pharmaceuticals’s Valuation Multiples Drop in 2016? Jul 08 2016
    Understanding the Valuation Catalysts for BioMarin in 4Q16 Jul 06 2016
    Hunting for value Jul 01 2016
    Deutsche Balaton AG :BBH-DE: Earnings Analysis: For the six months ended December 31, 2015 : June... Jun 29 2016
    Which Biotechnology Companies Could Benefit from Brexit? Jun 28 2016
    As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs Jun 23 2016
    Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead May 17 2016
    What Lies Ahead for Biotech ETFs? May 13 2016
    Will the Current Pipeline Help Medivation Go beyond Xtandi? May 12 2016
    The Story behind Medivation’s Rising Collaboration Revenue May 11 2016
    A Promising Uptake for Vertex’s Orkambi May 04 2016
    Biotech ETFs Sink on Mixed Q1 Results May 02 2016
    2 Dirt-Cheap Big Pharma Stocks Poised to Beat Biotech's Bad Rap May 02 2016
    Why Is Medivation at a Premium on an EV-to-EBITDA Basis? Apr 14 2016
    A Rare Opportunity With A Biotechnology ETF Mar 17 2016
    Is The Biotech Bear Market Over? Feb 29 2016
    6 Top-Ranked ETFs to Rebound on Bargain Hunt Feb 25 2016
    Some Traders Aren't Shy About Betting On A Biotech Rebound Feb 19 2016
    Biotech ETFs Slide as Stocks Report Mixed Q4 Results Feb 09 2016
    Tracking The Biotech Bubble's Bust Jan 31 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)